1-8 of 8
Mark Reding
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Bleeding Outcomes in Patients Who Switched From Sucrose-Formulated rFVIII to BAY 94-9027 Prophylaxis in PROTECT VIII

Mark Reding, MD, Thomas Moulton, MD, Erika Soltes Rak, Mindy L Simpson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-137565
Published: 2020
Journal Articles

Improvement in Quality of Life Outcomes and Bleeding Rates among Patients Switching from On-demand FVIII to Prophylactic BAY 94-9027 in the PROTECT VIII Study

Jonathan M. Ducore, MD MPH, Shadan Lalezari, PhD, Elena Santagostino, MD PhD, Sanjay P Ahuja, MD, Monika Maas Enriquez, Claudia Tueckmantel, PhD, Mark Reding
Journal: Blood
Blood (2019) 134 (Supplement_1): 1129.
https://doi.org/10.1182/blood-2019-123947
Published: 2019
Journal Articles

Real-World Effectiveness and Safety of BAY 94-9027 (Damoctocog Alfa Pegol) in Previously Treated Patients with Hemophilia A (HEM-POWR): Online Patient Portal and LIFE-ACTIVE Sub-Study

Johannes Oldenburg, María Teresa Alvarez Román, Giancarlo Castaman, Maissaa Janbain, MD, Tadashi Matsushita, Karina Meijer, Sabine Friedl, Martin Sanabria, Mark Reding
Journal: Blood
Blood (2019) 134 (Supplement_1): 4943.
https://doi.org/10.1182/blood-2019-128140
Published: 2019
Journal Articles

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Livia Hegerova, MD, Adam Bachan, Qing Cao, MS, Veronika Bachanova, MD PhD, Mark Reding, MD, John Rogosheske, PharmD, Brian McClune, DO, Aleksandr Lazaryan, MD PhD MPH, Greg M Vercellotti, MD FACP, Huong X Vu, PharmD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3695.
https://doi.org/10.1182/blood.V130.Suppl_1.3695.3695
Published: 2017
Journal Articles

Unmet Needs in Diagnosis and Treatment of Glanzmann’s Thrombasthenia (GT): Perceptions of US Hematologists and Nurses

Meera B. Chitlur, MD, Michael Recht, MD PhD, Madhvi Rajpurkar, MD, Ellis J. Neufeld, MD PhD, Craig M. Kessler, MD, Mark Reding, Michael Tarantino, MD, David L. Cooper, MD MBA
Journal: Blood
Blood (2014) 124 (21): 2179.
https://doi.org/10.1182/blood.V124.21.2179.2179
Published: 2014
Journal Articles

Impact of Glanzmann’s Thrombasthenia (GT): Perceptions from US Patients and Parents

Michael Recht, MD PhD, Madhvi Rajpurkar, MD, Meera B. Chitlur, MD, Mark Reding, Mary Jane Frey, RN, BSN, CPN, Skye Peltier, MPH, PA-C, Christine Guelcher, MS, PNP-BC, Dana Stephens, RN, MS, CPNP, David L. Cooper, MD MBA
Journal: Blood
Blood (2014) 124 (21): 4853.
https://doi.org/10.1182/blood.V124.21.4853.4853
Published: 2014
Journal Articles

Acquired Von Willebrand Disease – To Treat Or Not To Treat The Inhibitor?

Surbhi Shah, MBBS, Mark Reding
Journal: Blood
Blood (2013) 122 (21): 4744.
https://doi.org/10.1182/blood.V122.21.4744.4744
Published: 2013
Journal Articles

Incidence and Outcomes of Immune Thrombocytopenia (ITP) Following Hematopoietic Stem Cell Transplantation (HCT).

Milena Elimelakh, MD, Ted Eastlund, MD, Mark Reding, MD, Todd DeFor, MD, Linda Burns, MD
Journal: Blood
Blood (2007) 110 (11): 1316.
https://doi.org/10.1182/blood.V110.11.1316.1316
Published: 2007